Human cytomegalovirus (HCMV) is a ubiquitous pathogen with a predilection for dendritic cells (DCs). Latently infected myeloid progenitor cells develop into actively infected DCs with impaired functionality, allowing dissemination and transfer of virus throughout the body. However, the viral genes expressed in DCs and their effect on the cellular transcriptome are currently unknown. We investigated human DCs infected with HCMV by using SuperSAGE, allowing us to analyse the transcriptomes of both host and pathogen simultaneously. A small number of viral transcripts were expressed strongly and rapidly post-infection. However, only two were of the immediate-early class, including one with an unknown function. The viral genes expressed reflected the cellular milieu, with the majority having a known or suspected immune-evasion function. Several viral genes identified lack a known function and may fulfil specialized roles within DCs. The cellular response to infection included a strong interferon response, induction of cytokine and antiapoptotic genes and alterations in genes involved in antigen presentation. We demonstrated the validity of our approach by showing that novel changes first seen in the transcriptome were reflected in the phenotype of HCMV-infected DCs. Delineation of the transcriptional changes underlying the phenotype of HCMV-infected DCs allows a better understanding of how a herpesvirus infects DCs and pinpoints linkages between phenotype and specific viral genes.
INTRODUCTION
Human myeloid dendritic cells (DCs) are vulnerable to infection by many different viruses. The genes expressed within DCs, both viral and cellular, are of particular interest to understand how viruses evade the immune response and replicate in these rare cells. Recent research has revealed the changes in cellular transcripts taking place in DCs upon infection with RNA viruses (Huang et al., 2001; Izmailova et al., 2003; Zilliox et al., 2006) , but no data are available for herpesviruses. The betaherpesvirus human cytomegalovirus (HCMV) is a clinically relevant DNA virus that causes significant pathology in immunosuppressed patients and newborn infants. HCMV infects and becomes latent in myeloid progenitor cells (Maciejewski et al., 1992; Kondo et al., 1994; Mendelson et al., 1996; Sindre et al., 1996) . These give rise to more differentiated cell types, such as macrophages or DCs, where HCMV can reactivate (Ibanez et al., 1991; Lathey & Spector, 1991; Kondo et al., 1994; Raftery et al., 2001; Reeves et al., 2005) . This DC tropism, combined with the large number of immune-evasion genes of unknown function, makes HCMV infection particularly interesting. Although infection of DCs with HCMV has been shown to induce pronounced phenotypic and functional changes, neither the underlying transcriptional alterations nor the identity of the viral genes responsible has been investigated. We furthermore hypothesized that the viral transcriptome might be altered to accommodate replication in these potent antigen-presenting cells. To investigate this infection model, we used the newly developed SuperSAGE technique (Matsumura et al., 2005) . A strength of this method is that we can rapidly derive unambiguous transcript sequence information from both host and pathogen (Matsumura et al., 2003 (Matsumura et al., , 2006 . DCs are a pivotal part of the immune system and the changes that take place upon exposure to pathogens determine the nature of the immune response (Guermonprez et al., 2002) . In the absence of interference from the pathogen, DCs mature into antigen-presenting cells with a very high T-cell-stimulatory capacity, allowing efficient presentation of pathogen-derived antigens to specific T cells. DCs sense the presence of invading organisms by pattern-recognition receptors (PRRs) (Gordon, 2002; Geijtenbeek et al., 2004; Inohara et al., 2005) . PRRs have furthermore been shown to act synergistically (Napolitani et al., 2005) , so that the mix of pathogen-associated molecular patterns on each invading organism results in a unique transcriptional 'fingerprint', thus allowing an appropriate immune response. HCMV has been shown to bind to Toll-like receptor 2 (TLR2) (Compton et al., 2003) and DC-SIGN (Halary et al., 2002) . Murine cytomegalovirus infection has been shown to be controlled primarily by TLR9 and TLR3 (Tabeta et al., 2004; Zucchini et al., 2008) , and it is likely that other PRRs also react to HCMV infection. Many viruses thus encode molecules that attempt to block cellular responses in order to evade the immune response, such as vaccinia virus A52R (Harte et al., 2003) , which blocks TLR signalling, and herpes simplex virus (HSV) virion host shutoff protein (vhs), which causes a broad downregulation of cellular mRNA (Fenwick & McMenamin, 1984) .
By using SuperSAGE, we examined the expression of HCMV and cellular genes simultaneously, thereby identifying those viral genes expressed strongly in DCs shortly after infection, as well as the response of DCs to infection. These data were confirmed by RT-PCR, quantitative RT-PCR (qRT-PCR) and flow cytometry. The viral genes identified, for example UL22A, give a valuable insight into the immune-evasion genes that may be particularly important in DCs. The cellular changes identified, for example the downregulation of IRAK1, contribute mechanistic explanations of the phenotype of HCMV-infected DCs.
METHODS
Cells. Human DCs were generated from buffy-coat preparations supplied by the German Red Cross, Berlin, Germany. CD14 + monocytes were isolated from peripheral blood mononuclear cells by antibody-coupled magnetic beads (Miltenyi Biotech) and cultured in fetal calf serum-free CellGro DM medium (CellGenix) supplemented with 100 IU penicillin ml 21 , 100 mg streptomycin ml 21 , 4.5 mM glutamine (PAA Laboratories), 500 U granulocyte-macrophage colony-stimulating factor ml 21 and 200 IU interleukin-4 ml 21 (Immunotools). Half of the medium was changed on day 3 after isolation and the entire medium was changed at day 6, when the DCs were used for experiments. The DCs were 98 % pure as determined by staining for CD83 and CD3.
Viruses and infection. For the generation of SuperSAGE libraries, immature DCs from one donor were divided into two portions (2610 7 cells each) and infected with HCMV clinical strain MOLD at an m.o.i. of 5, whilst control cells remained untreated. Strain MOLD was isolated from a bronchoalveolar-lavage specimen post-renal transplantation. Twelve hours after infection, cells were harvested and washed once with PBS before collection of RNA and library generation. For confirmation of SuperSAGE results, RNA was isolated from DCs prepared from six further donors 12 h post-infection. DCs from two donors were also infected for 3-5 days before cytospin and fixation by acetone/methanol. Active infection was confirmed by immunocytological staining for HCMV immediate-early (IE) proteins using mAb E13 (Tebu) or gB mAb 1 M-12 (Biodesign). Further aliquots of cells were analysed for active infection. Infected cells were lysed by three freeze-thaw cycles and the lysate was used to infect fibroblast monolayers. Alternatively, cells were incubated for 6 days before the cells were centrifuged, washed and added to monolayers of fibroblasts. Monolayers were washed after 12 h. Infected fibroblasts were cultivated for a further 2 days before fixation and immunocytological staining. Infectious foci were then compared with the number of DCs added to the wells to determine the percentage of DCs infected productively with HCMV.
RNA preparation. For SuperSAGE, total RNA was extracted by using the Total RNA isolation system (Promega) and the quality of RNA was tested on a 1 % agarose gel by checking the integrity of the 18S and 28S rRNA bands. From 125.6 and 77.6 mg total RNA of the uninfected and HCMV-infected samples, we purified mRNA with an mRNA purification kit (Amersham Biosciences), yielding 3.6 and 3.1 mg mRNA, respectively.
RNA amplification with T7 RNA polymerase. Purified mRNA was converted into cDNA by using the cDNA Synthesis system (Invitrogen) and a biotinylated oligo(dT) primer for first-strand synthesis containing a recognition site of the tagging enzyme EcoP15I (underlined) (59-biotin-CTGATCTAGAGGTACCGGATCCCAGC AGTTTTTTTTTTTTTTTTT-39). cDNA was digested with NlaIII (NEB) and bound to Streptavidin MagneSphere Paramagnetic Particles (Promega). To amplify RNA without bias using T7 RNA polymerase, a T7 SAGE adaptor was prepared as described by Vilain et al. (2003) . A 200 ng aliquot of this adaptor was ligated to the cohesive ends of the NlaIII-cleaved and immobilized cDNA with 10 U T4 DNA ligase (Invitrogen) at 16 uC for 2 h. After four washes with 5 mM Tris (pH 7.5), 0.5 mM EDTA, 1 M NaCl, three washes with 3 mM Tris (pH 7.5), 0.2 mM EDTA and one wash with DEPC water, transcription of RNA was performed with a MEGAscript T7 High Yield Transcription kit (Ambion). Supernatants containing the amplified RNA were collected, digested with DNase I and precipitated, yielding 26.9 and 24.9 mg amplified RNA (uninfected and HCMV-infected samples, respectively). Although the majority of viral mRNA is polyadenylated and will be detected by this method, viral transcripts without polyadenylation also exist (Plachter et al., 1988; Mach et al., 1989; Adair et al., 2004) .
Generation of SuperSAGE libraries. Amplified RNA was converted into cDNA and digested with the anchoring enzyme NlaIII as decribed above. Generation of SuperSAGE libraries was performed by following a published protocol (Matsumura et al., 2003) with minor modifications. Linker-ligated cDNA on the magnetic beads was digested with 20 U His 6 -tagged EcoP15I. DNA fragments separated by PAGE were visualized by SYBR Green (Sigma-Aldrich) staining.
The type III restriction endonuclease EcoP15I used in SuperSAGE (Möncke-Buchner et al., 2004) recognizes the asymmetrical hexameric sequence CAGCAG9 as a pair in inverted orientation. It cuts the DNA 24-26 nt in the upper strand and 26-28 nt in the complementary strand downstream of the recognition site, creating a 59 overhang of two bases (Meisel et al., 1992; Wagenführ et al., 2007) . After filling in this overhang, tags that are predominantly 27 bp long can be extracted (Matsumura et al., 2003) .
RT-PCR and qRT-PCR
Total RNA was extracted from cells and cDNA was synthesized by using oligo(dT) primer and SuperScript II reverse transcriptase (Invitrogen).
RT-PCR. To quantify gene expression of viral genes, conventional PCR was performed in 20 ml reactions using cDNA corresponding to 5 ng total RNA. HCMV-specific primers used are shown in Supplementary Table S1 (available in JGV Online). Reaction mixtures were incubated in a PX2 thermocycler (Hybaid). After 35 cycles, 10 ml aliquots were analysed on a 2 % agarose gel. Data were collected from three donors.
qRT-PCR for chemokine genes. mRNA was isolated from 10 6 cells with a MagnaPure-LC device (Roche) and reverse-transcribed by using avian myeloblastosis virus reverse transcriptase and oligo-(dT) as primer (First Strand cDNA synthesis kit; Roche) in a thermocycler, according to the manufacturer's protocol. Primer sets for CCL4, CCL5, CXCL10 and CD83 optimized for the LightCycler (Roche) were developed and provided by Search-LC GmbH. PCR was performed with a LightCycler FastStart DNA SYBR Green I kit (Roche) according to the protocol provided in the parameter-specific kits. To correct for differences in the content of mRNA, the calculated copy numbers were normalized according to the mean expression of two housekeeping genes, cyclophilin B and b-actin. Data were collected from three donors.
qRT-PCR for other genes. To confirm gene expression of MX1, B2M, CD74, IRAK1, HLA-DRB5, HLA-DPB1 and RNPEPL1, SYBR Green real-time PCR was performed. Gene-specific primers used for MX1, B2M, IRAK1 and b-actin, designed by using Primer 3 software (Rozen & Skaletsky, 2000) , are shown in Supplementary Table S1 . Genespecific primers for CD74, HLA-DRB5, HLA-DBP1 and RNPEPL1 were obtained from Biomol. Mean fold ratio of up-or downregulation of genes expressed differentially in uninfected and HCMVinfected DCs was calculated by using the 2 {DDCt method. Results were confirmed internally against b-actin as the standard gene. Specificity of melting curves was also checked. Data were collected from three donors.
Flow cytometry. Cell-surface and intracellular staining was performed by standard procedures (Raftery et al., 2001) . Intracellular permeabilization was performed by using saponin. Cells were analysed by flow cytometry using a FACScalibur (BD Biosciences). Primary antibodies were supplied by BD Biosciences.
Western blotting. Western blotting was performed by standard procedures (Raftery et al., 2008) . Rabbit polyclonal antibodies against IRAK (Upstate Biotechnology) at a 1 : 500 dilution and b-actin (Abcam) diluted 1 : 10 000 were used.
Data analysis. For annotation of the SuperSAGE tags, the GenBank (RefSeq) database was searched by BLASTN 2.2.10 using the 26 bp tag sequences as query. Statistical significance (P-value) was computed by the SAGE 2002 software (Johns Hopkins University, Baltimore, MD, USA). Statistical analysis of qRT-PCR and flow cytometry data was done by calculating DDC t and paired t-tests.
RESULTS

HCMV infection of DCs
In order to generate SuperSAGE libraries, DCs generated from CD14
+ monocytes were treated with HCMV. DCs were collected after 12 h infection and mRNA was extracted. In order to assess the degree of infection, aliquots of DCs were cultivated for 3 days before being fixed and stained for HCMV IE1 and IE2 proteins (Fig. 1a , first row) or were cultivated for 5 days before being fixed and stained for the late viral glycoprotein gB (Fig. 1a , second row). The DCs were 55 % positive for HCMV IE1/ IE2. To confirm that the infection was productive, HCMVinfected DCs from two donors were cultivated for 6 days before being washed and added to fibroblast monolayers. After 12 h, DCs were washed off the fibroblasts, which were incubated for a further 2 days before being fixed and stained for HCMV IE1 and IE2 proteins. As HCMVinfected DCs release little free virus, but instead transfer infection primarily by cell-cell contact, we compared the number of DCs inoculated with the number of virus plaques and determined that .50 % of DCs were infected productively (Fig. 1b) . Analysis of cellular lysates used to infect fibroblast monolayers indicated an increase in virus titre over time (Fig. 1c) . The phenotype of DCs at 3 days post-infection was also tested by staining for CD83, demonstrating maturation of DCs after exposure to virus (Fig. 1d ). This maturation was, however, reduced significantly compared with the same quantity of UV-inactivated virus. These data confirm that DCs infected productively with HCMV had an altered phenotype.
Construction and analysis of SuperSAGE libraries
Next, two independent SuperSAGE libraries were constructed from amplified mRNA isolated from untreated DCs and DCs infected with HCMV. These libraries were annotated by using a tag size of 26 bp and genes representing the tag sequences were identified by BLASTN search in the RefSeq and GenBank databases. In total, 10 209 and 9966 SuperSAGE tags (uninfected and HCMV-infected DCs, respectively) were extracted, representing 6023 and 5948 different transcripts; 53 and 34 of them occurred with an absolute tag number of at least 15, and 4983 and 5131 tags were detected only once. Transcripts that were expressed differentially to a significant degree (P,0.05) were analysed by using a BLASTN search in the RefSeq or GenBank database and were found to include both viral (Table 1) and cellular  (Tables 2 and 3) sequences. Transcripts that were expressed strongly, but not altered significantly (see Supplementary  Table S2 , available in JGV Online), included several housekeeping genes.
The most frequent transcripts identified in uninfected cells were associated with antigen presentation, namely the HLA-DRa chain (HLA-DRA) (3.1 %) and CD74 (3.1 %), followed by the chemokine CCL22 (1.0 %). In contrast, the chemokines CCL4 (2.5 %) and CCL8 (1.6 %), but not CCL22, were very abundant post-infection. Further analysis of the tables showed that several groups of cellular genes, including antigen presentation, chemokines, interferon-stimulated genes (ISGs), apoptosis-associated, ribosomal and translation-initiation proteins, were regulated by HCMV infection.
HCMV genes expressed in DCs
To find HCMV genes expressed in HCMV-infected immature DCs, we screened for tags matching the HCMV sequence. The total number of tags derived from HCMV was 61, representing 0.61 % of all tags extracted from the HCMV-infected sample. None of these tag sequences was found in the uninfected sample. HCMV tags that occurred twice or more were assigned to the genome of HCMV (Table 1) . Tag sequences were annotated to HCMV strain AD169 except for UL145, which was annotated to strain Toledo. The small library size of 10 000 tags allowed only the most actively transcribed viral genes to be identified, whereas several other viral transcripts were represented by only one tag.
As confirmation of our SuperSAGE results, we performed RT-PCR for HCMV US3, US8, US10, US12 and UL6. We confirmed transcription of all of these genes upon HCMV infection of DCs (Fig. 2a) , but not of UL83, which was not detected in our SuperSAGE analysis and thus served as a negative control. The absence of the US3 transcript when the DCs were treated with actinomycin D before infection (Fig. 2b) , in contrast to the presence of both the spliced and unspliced transcripts in the presence of cycloheximide, demonstrated clearly that the IE gene US3 was freshly transcribed post-infection. A time-course analysis of IE1 and US12 expression post-infection (Fig. 2c ) demonstrated that US12 was expressed more strongly than the IE1 transcript and was present from 4 h post-infection. Viral genomic DNA was used to confirm that amplification of product by both primer sets was equally efficient and that the IE1 detected in DCs was spliced. In our SuperSAGE analysis, the IE1 signal was below the cut-off point; however, the US12 signal was above this cut-off point. This demonstrates that the viral genes detected by SuperSAGE accurately reflect the viral transcriptome expressed early post-infection in DCs.
The signal of the commonest HCMV transcript, b2.7 (0.26 %), was only 21-fold weaker than that of the commonest cellular transcript, illustrating the strength of viral transcription in DCs. The b2.7 transcript encodes RL4 and is also the commonest HCMV transcript in fibroblasts.
This transcript blocks apoptosis by interaction with GRIM19 (Reeves et al., 2007) . In accordance with the status of the DC as the premier antigen-presenting cell, many of the remaining viral genes have a known or suspected role in immune evasion (Table 1) . It is known that clinical strains lose a group of genes upon prolonged passage in fibroblasts and, at the same time, lose the ability to infect DCs productively (Raftery et al., 2001) . One member of this group, UL145, was detected in our study and thus represents a good candidate for a gene involved in productive HCMV infection of DCs. Viral transcripts detected by SuperSAGE were due to active infection and not due to virion-associated mRNA (Bresnahan & Shenk, 2000; Greijer et al., 2000) , as demonstrated by RT-PCR of HCMV-infected DCs treated with a blocker of transcription, actinomycin D (Fig. 2b) . Thus, in DCs, a small number of viral genes were transcribed strongly.
To demonstrate the validity of our findings, we investigated one viral gene further. UL145 is a putative open reading frame (ORF) encoding a 130 aa protein of unknown function. Semiquantitative RT-PCR of cDNA generated from cycloheximide-treated HCMV-infected DCs clearly demonstrated the presence of UL145 (Fig.  3a) . Transcription of UL145, despite the blockage of protein synthesis by cycloheximide treatment, shows that UL145 belongs to the IE class of genes. To confirm this, we cloned the 300 bp region upstream of UL145 into a promoterless plasmid encoding green fluorescent protein (GFP), giving plasmid p145-GFP. This was compared with a similar plasmid encoding the promoter for US10 (763 bp upstream of US10, giving plasmid p10-GFP), the original plasmid (pCD-GFP, derived from pcDNA3.1; Invitrogen) Table 3 . cont.
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and plasmid pEF-GFP, where GFP was under the control of the human elongation factor 1a (hEF1a) promoter (derived from pEF6; Invitrogen). Transfection of HEK293 cells with p145-GFP resulted in GFP expression and gave a promoter strength of 20 % relative to the HCMV major IE promoter found in pCD-GFP, or of 30 % relative to the hEF1a promoter found in pEF-GFP (Fig. 3b) . The US10 promoter, however, showed no activity in HEK293 cells. Interestingly, when UL145 was cloned into pEF6, giving pEF-UL145, and cotransfected with pCD-GFP, significant enhancement of GFP expression was seen (Fig. 3c) , indicating that UL145 enhances transcription driven by the HCMV major IE promoter.
Myeloid progenitor cells represent a model of true HCMV latency (Kondo et al., 1994; Mendelson et al., 1996; Sindre et al., 1996; Goodrum et al., 2002 Goodrum et al., , 2004 Cheung et al., 2006) , whereas the DC is a model of reactivation/ productive infection after differentiation of CD34 + cells (Reeves et al., 2005) . In line with this, the HCMV transcripts specific for latency (Kondo et al., 1994) were not seen in DCs. Of the viral ORFs that we detected, b2.7/ RL4, US12 (Goodrum et al., 2002 (Goodrum et al., , 2004 Cheung et al., 2006) , UL145, US8, US10, US34 (Goodrum et al., 2002 (Goodrum et al., , 2004 and UL6 (Cheung et al., 2006) have been reported previously by microarray analysis of CD34 + progenitor cells or subsets thereof. UL22A, UL48A and US3 were expressed in the differentiated DC cell type, but have not been detected in latency models. UL22A was either not detected in myeloid progenitors (Cheung et al., 2006) or not present in the virus strain used (Goodrum et al., 2002 (Goodrum et al., , 2004 , so we assign it to the aforementioned group. One possible interpretation is that UL22A and US3 represent immune-evasion molecules particularly specialized for this highly active antigen-presenting cell, as opposed to myeloid progenitor cells. The mix of immune-evasion/anti-apoptosis functions seen in the entire group appears well-suited to help to protect the virus after reactivation from latency.
Cellular gene-expression profile of HCMVinfected DCs
Statistical analysis of the tag abundance between uninfected and HCMV-infected populations showed 38 increased and 57 downregulated (P,0.05) cellular transcripts (Tables 2 Table S2 ).
To identify cellular genes that were most likely to be regulated specifically by HCMV, we compared our data with previously published microarray data of HCMV infection of myeloid progenitor cells (Slobedman et al., 2004) and fibroblasts (Simmen et al., 2001; Zhu et al., 1998) . We further compared our data with RNA virus infection of DCs (Huang et al., 2001; Zilliox et al., 2006) . The cellular genes QKI, G1P3, HLA-DPB1, ECGF and GRIM19 are altered by HCMV infection in DCs, but have not been reported previously to be affected either by HCMV infection or in RNA virus-infected DCs. Both G1P3 and GRIM19 have been associated with inhibition of apoptosis (Cheriyath et al., 2007; Reeves et al., 2007) .
In Table 2 , showing upregulated genes, CD74, a protein involved in MHC (major histocompatibility complex) class II antigen presentation, is the most abundantly transcribed gene in infected DCs, with expression nearly double that in uninfected cells. qRT-PCR analysis confirmed this increase and the upregulation of HLA-DPB1 (Fig. 4a) . The genes induced most strongly by HCMV infection included three chemokines (CCL5, CCL8, CXCL10) and the ISGs MX1 and G1P2 (Table 2) . Upregulation of CCL4, CCL5 and CXCL10 is characteristic of DC maturation (Hashimoto et al., 2000; Sallusto et al., 1999) and is also seen after measles virus infection of DCs (Zilliox et al., 2006) . We confirmed the upregulation of CCL4, CCL5 and CXCL10 from 0 to 12 h by using qRT-PCR (Fig. 4a, c) . ISGs were induced strongly by HCMV infection, as has been reported previously in fibroblasts (Simmen et al., 2001; Zhu et al., 1998) . Upregulation of the ISG MX1 was also confirmed by qRT-PCR (Fig. 4a) . MX1 is a GTPase with a broad antiviral action against many classes of virus (reviewed by Haller & Kochs, 2002) and the strong expression of MX1 indicates that viral interferon-blocking mechanisms may be only partially effective in DCs. Upregulation of the light chain of MHC class I (B2M) was also confirmed by qRT-PCR (Fig.  4a) . Another upregulated gene of interest is SERPINB9, a granzyme B inhibitor that has also shown to be upregulated after HCMV infection post-kidney transplantation (Rowshani et al., 2005) . As DCs are one of the major sources of SERPINB9, this gene may protect the infected antigen-presenting cell from cytotoxic attack. Table 3 shows 57 downregulated genes in HCMV-infected immature DCs. The alpha chain of HLA-DR is the most commonly expressed gene in uninfected DCs, and was downregulated by HCMV infection (from 312 to 214 tags; Table 3 ). The transcript for the beta chain of HLA-DR (alleles 1 and 5) was also downregulated, as confirmed by qRT-PCR of HLA-DRB5 (Fig. 4b) . IRAK1 is a critical adaptor molecule transmitting TLR-mediated signals from MyD88 to induce NF-kB activation. We saw a strong downregulation of IRAK1 and RNPEPL1 upon infection, which we confirmed by qRT-PCR (Table 3 ; Fig. 4b ). IRAK1 downregulation was also confirmed by Western blotting (Fig. 5b) . Downregulation of IRAK1 was accompanied by a block in maturation in response to TLR2 or TLR4 ligands (Fig. 5c) . It is particularly interesting that 20 ribosomal proteins and four translation factors were downregulated by HCMV infection (Table 3) , implying a global block in translation post-infection. This downregulation may be potentiated further by transcripts such as IFIT1, which is known to inhibit eIF3e (Hui et al., 2003) . In addition, the downregulation of the mitochondrial ATPase (MT-ATP6) and the mitochondrial cytochrome c oxidase subunit II (MT-CO2) ( Table 3 ) parallels downregulation of genes in the oxidative phosphorylation pathway seen during measles virus infection (Zilliox et al., 2006) . Finally, our results indicate an unexpected divergence in genes controlled by the class II transactivator (CIITA). A strong downregulation of transcripts encoding HLA-DR SuperSAGE analysis of HCMV-infected DCs alpha and beta chains (Table 3) occurred at the same time as upregulation of HLA-DP beta chain and CD74 (Table  2) . Although this upregulation could be interpreted as a transient effect, as has been described previously (Landmann et al., 2001) , this was not the case here, as intracellular flow cytometry showed HLA-DP upregulation at 2 days post-infection (Fig. 5a ).
DISCUSSION
By using SuperSAGE to investigate DCs infected with HCMV, we have analysed the transcriptome of a central element of the immune response infected with a clinically significant pathogen. During the life cycle of HCMV, latently infected myeloid progenitors develop into more differentiated forms such as DCs, allowing virus reactivation (Reeves et al., 2005) , replication and dissemination to endothelial, epithelial and fibroblast cells, where full productive replication takes place. DCs thus not only are the differentiation stage where myeloid cells have their most potent antigen-presenting function, but also support a critical stage in the life cycle of HCMV. SuperSAGE enables the simultaneous analysis of both the effect that the virus has on host gene expression and the viral genes that HCMV uses to infect DCs. An early time point postinfection was chosen to minimize cellular apoptosis and to simplify the pattern of viral genes and the cellular response, so as to give the best chance of identifying viral immuneevasion genes. There are a number of interesting aspects of the HCMV genes expressed in DCs. The predominance of transcripts with an immune-evasion function suggests virus adaptation to infection of these potent professional antigenpresenting cells. Only one of the viral genes expressed strongly in DCs is defined as essential for replication in fibroblasts, and several more have no known function. Unexpectedly, the transcripts were predominantly early or late, whereas only two IE transcripts (US3, immune evasion; UL145, unknown) were present above the assay cut-off point (two tags). A similar phenomenon, however, has been reported to occur shortly after HCMV infection of myeloid progenitor cells (Goodrum et al., 2002 (Goodrum et al., , 2004 Cheung et al., 2006) . Our data also indicate that several HCMV immuneevasion genes are expressed strongly in DCs. For example, we show that HCMV-infected DCs express both CCL5 and UL22A, which has been shown to selectively block CCL5 (Wang et al., 2004) . Interestingly, neither CCL5 nor UL22A is detected in HCMV-infected myeloid progenitor cells, where the virus is latent. It is probable that strongly expressed viral genes with an unknown function, for example UL145, have a specialized role in DCs. Our data further support the idea that, in DCs, the viral transcriptome is altered, presumably to provide immune evasion optimized for DCs and to promote infection.
By examining the host transcriptome and comparing it with published data, we saw several features defining HCMV infection of DCs. Many of the changes could be related to DC maturation, e.g. the induction of ISGs and chemokines, which are regulated in a similar fashion in response to several pathogens or PRR-mediated signals (Huang et al., 2001) . A number of individual transcripts were, however, regulated uniquely by HCMV, of particular interest being HLA-DPB1, GRIM19, PEA15, LY6E and IRAK1. Furthermore, the potent downregulation of transcripts encoding ribosomal proteins and transcription factors has only been reported previously in connection with measles virus and DCs (Zilliox et al., 2006) .
Several apoptosis-related transcripts were affected by HCMV infection. The upregulation of PEA15 and BIRC3 and downregulation of GRIM19 may help to protect from apoptosis, particularly in response to TRAIL, which is induced by both type I interferon and HCMV infection (Raftery et al., 2001; Simmen et al., 2001) , enhancing cytotoxicity. HCMV may also attempt to protect DCs from TRAIL-mediated apoptosis by upregulation of G1P3, which is known to confer resistance (Cheriyath et al., 2007) . GRIM proteins are associated with retinoic acidand interferon-induced mortality, and GRIM19 is a frequent target of herpesvirus immune evasion (Seo et al., 2002; Yeo et al., 2008) . Recent research has demonstrated an association between the b2.7 transcript of HCMV and the GRIM19 protein (Reeves et al., 2007) . The discovery that, in DCs, the transcription of GRIM19 is also downregulated implies an unsuspected, additional blocking mechanism.
Cytomegalovirus-infected DCs have been reported to be refractile to lipopolysaccharide stimulation (Andrews et al., 2001) . In this context, IRAK1, a critical intermediate in TLR signalling, is of particular interest. The appearance of tolerance of DCs to repeated TLR2 and TLR4 maturational signals is a well-known phenomenon in which IRAK1 breakdown has been implicated (Jacinto et al., 2002; Siedlar et al., 2004) . HCMV stimulates TLR2 (Compton et al., 2003) , but downregulates IRAK1 transcription and expression and inhibits further stimulation by TLR2 or TLR4. Blockage of TLR signalling as a viral immune-evasion strategy has been demonstrated in vaccinia virus infection (Harte et al., 2003) and may be the cause of the functional defect seen in HCMV-infected DCs (Raftery et al., 2001) . Downregulation of ribosomal proteins and transcription factors was a prominent feature of HCMV infection of DCs. Transcripts for some ribosomal proteins have been shown to be reduced post-HCMV infection in fibroblasts (Kenzelmann & Muhlemann, 2000; Simmen et al., 2001) , but this does not occur during HCMV infection of myeloid progenitor cells (Slobedman et al., 2004) , suggesting that it is a feature of productive infection. This potent reduction of multiple ribosomal proteins and translation factors points towards a global inhibition of translation in HCMVinfected DCs. This may help to explain why HCMVinfected DCs are more vulnerable to apoptosis (Raftery et al., 2001) , due to the breakdown of labile anti-apoptotic proteins. An analogous strategy is used by HSV, where host protein expression is blocked, although in this case the HSV vhs causes a global downregulation of mRNA and not a block in translation (Fenwick & McMenamin, 1984 ).
In conclusion, by using SuperSAGE in DCs, we have been able to both pinpoint viral and cellular genes of interest and describe alterations in several broad categories of gene. Furthermore, the changes that we describe explain known properties of HCMV-infected DCs. The action of these transcriptional changes in the context of virus-induced translational shutdown, and how DC-specific viral transcripts manage to be expressed in this milieu and block the immune system, will be a very interesting topic for the future.
